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Abstract

Öz

Objective: The general public recognizes the connections between
obesity, family history of diabetes (FHD), and diabetes, but remains
unaware of synergistic effects that occur due to their combination.
In this study, we investigate the synergistic effects of event diabetes
between snoring, FHD, and obesity.
Materials and Methods: Study subjects were selected among
participants in the Korean Genome and Epidemiology Study AnsanAnsung cohort, an ongoing prospective population-based study.
Ansan-Ansung cohort initiated in 2001 and 2002 and has been followed
biennially. At baseline, the initial cohort of 10.030 subjects, aged 40
to 69 years. A total of 5.759 participants were included in this study.
The relationships between diabetes and snoring, FHD, and obesity
were estimated using Cox hazard regression models after adjusting
for confounding factors. Snoring, obesity and FHD were significantly
associated with diabetes in both males and females after adjustments
for covariates. However, males were significantly more likely to have
FHD and obesity.
Results: A synergistic effect between these two risk factors showed that
being female was associated with the all group after adjustment for
covariates. Moreover, there was a high risk of having two risk factors
among female patients, while males showed no such tendency. A
significant synergistic effect between these three risk factors was seen in
females. An exposure group with these three factors had higher diabetes
risk than other groups [hazard ratio (HR): 6.27 (95% confidence
interval (CI): 2.93-13.41] p<0.01, but this was not seen in males.
Especially, premenopausal women was showed significant with FHD,
obese, habitual snorer [HR=5.69 (95% CI: 2.31-14.02) p<0.01]. But
postmenopausal women was showed significant with FHD and habitual
snorer both non-obese and obese [HR=7.22 (95% CI: 1.68-30.99)
p=0.01 and HR=7.85 (95% CI: 1.88-32.82) p<0.01, respectively].

Amaç: Toplum, obezite, ailede diyabet öyküsü (ADÖ) ve diyabet
arasındaki bağlantıların farkındadır, ancak bunların kombinasyonundan
kaynaklanan sinerjik etkilerin farkında değildir. Bu çalışmada, diyabet
olgusunun horlama, ADÖ ve obezite arasındaki sinerjik etkilerini
araştırdık.
Gereç ve Yöntem: Çalışmadaki denekler, devam eden, ileriye dönük
popülasyon tabanlı bir çalışma olan Kore Genom ve Epidemiyoloji
Çalışması Ansan-Ansung kohortundaki katılımcılar arasından seçildi.
Ansan-Ansung kohortu 2001 ve 2002’de başlatıldı ve iki yılda bir takip
edildi. Başlangıçta, 10,030 denekten oluşan ilk kohortun yaşları 40 ile
69 arasında değişmekteydi. Bu çalışmaya toplam 5,759 katılımcı dahil
edilmiştir. Diyabet ve horlama, ADÖ ve obezite arasındaki ilişkiler,
karıştırıcı faktörler için uyarlandıktan sonra Cox tehlike regresyon
modelleri kullanılarak tahmin edildi. Horlama, obezite ve ADÖ, ortak
değişkenler için düzenlemelerden sonra hem erkeklerde hem de
kadınlarda diyabet ile anlamlı derecede ilişkili bulundu. Bununla birlikte,
erkeklerin ADÖ ve obezite olma olasılığı önemli ölçüde daha yüksekti.
Bulgular: Bu iki risk faktörü arasındaki sinerjik bir etki, ortak değişkenler
için düzeltme yapıldıktan sonra kadın olmanın tüm grupla ilişkili
olduğunu gösterdi. Dahası, kadın hastalarda iki risk faktörüne sahip olma
riski yüksekken, erkekler böyle bir eğilim göstermiyordu. Kadınlarda
bu üç risk faktörü arasında önemli bir sinerjik etki görülmüştür. Bu üç
faktöre sahip bir maruziyet grubu diğer gruplardan daha yüksek diyabet
riskine sahipti (tehlike oranı (HR) 6,27 [%95 güven aralığı (GA): 2,9313,41] p<0,01, ancak bu erkeklerde görülmedi. Özellikle premenopozal
kadınlarda ADÖ, obezite, habitüel horlama anlamlı idi [HR=5,69 (%95
GA: 2,31-14,02) p<0,01]. Ancak menopoz sonrası hem obez hem de
obez olmayan kadınlarda ADÖ ve habitüel horlama ile anlamlı ilişki
görüldü [HR=7,22 (%95 GA: 1,68-30,99) p=0,01 ve HR=7,85 (%95 GA:
1,88-32,82) p<0,01, sırasıyla].
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Abstract

Öz

Conclusion: The combination of obesity, FHD, and habitual snoring was
associated with greater susceptibility to diabetes in female patients, while
obesity and habitual snoring was associated with greater susceptibility
to diabetes in males.
Keywords: Incident diabetes, risk factor, coexistence, snoring, family
history, obese

Sonuç: Obezite, ADÖ ve habitüel horlama kombinasyonu kadın
hastalarda diyabete yatkınlıkla ilişkiliyken, erkeklerde ise obezite ve
habitüel horlama diyabete yatkınlıkla ilişkiliydi.
Anahtar Kelimeler: Diyabet olgusu, risk faktörü, koekzistans, horlama,
aile öyküsü, obezite

Introduction

non-obese men and premenopausal women (1.69-fold and
2.31-fold, respectively) (12). Interestingly, female sex plus
habitual snoring have been consistently associated with diabetes
(14), while the same relationship is controversial in males (17).
Therefore, questions about gender differences remain.
In this study, we examined not only the effects of FHD, obesity,
and snoring on incident diabetes, but also any synergistic
effects between these risk factors according to sex.

Diabetes is the most common endocrine disease, caused by
the persistence of hyperglycemia due to abnormalities in
insulin resistance and beta-cell dysfunction (1). During the
past few decades, the prevalence and incidence of diabetes
have increased worldwide (2). Diabetes is an important public
health issue that is associated with high rates of morbidity and
mortality (3).
Diabetes is a multifactorial disease resulting from the complex
interplay of polygenic genetic and behavioral factors, and
environmental influences (4). Understanding family histories of
disease is a simple but clinically powerful tool because family
members share similar genetic, cultural, and behavioral traits.
Family history of diabetes (FHD) is an important risk factor for
developing diabetes, because having one family member with
FHD was associated with 2.5-fold increased risk of diabetes.
Moreover, biparental FHD conferred even 5.14-fold higher risk
(5).
Obesity is increasing rapidly worldwide (6). One consequence
of obesity is an increased risk of developing diabetes (7). In
previous studies, in a corroborating study, FHD with obesity
30≤ Body Mass index (BMI) was more strongly associated with
diabetes (5.7-fold) than either were alone (2.59-fold for BMI and
2.41-fold for FHD) (8). Moreover, the prevalence of impaired
glucose tolerance (IGT) and non-insulin dependent diabetes
were associated with a 3-fold increase in FHD in patients with
obesity and central obesity (9). As shown in a meta-analysis,
obesity is a major contributor to the development of diabetes
(10), while reduced weight amplifies health benefits because
it leads to improvements in fasting glucose, lipoprotein, and
blood pressure. Consequentially, obesity is a modifiable risk
factor that can be changed by lifestyle modifications.
Snoring is not only an important signal for sleep-disordered
breathing, but it is independently associated with many
diseases including abnormalities of insulin secretion, insulin
action, hemoglobin A1C, and diabetes (11-15). In addition, a
recent meta-analysis reported 1.37-fold a significant association
between diabetes and habitual snoring (16). The effects of
obesity and snoring in incident diabetes have been compared
based on the presence or absence of these risk factors in
males (14). Lack of snoring and obesity were independently
associated with incident diabetes (5.1-fold). Moreover, habitual
snoring and obesity together result in significantly higher risk
of diabetes than either does alone (7.0-fold). Habitual snoring
without obesity is not associated with incident diabetes, while
habitual snoring is related to increased HbA1c levels in both

Materials and Methods
Study Subjects and Populaiton
Study subjects were selected among participants in the Korean
Genome and Epidemiology Study, an ongoing prospective
population-based study among the Ansan-Ansung cohort of
middle-aged and older adults in Korea (18). The Ansan-Ansung
cohort was initiated in 2001 and 2002 and has been followed
biennially. At baseline, the initial cohort of 10.030 subjects, aged
40 to 69 years, were randomly recruited from two sites, with
5.012 subjects from the urban community of Ansan (2.518 men
and 2.494 women) and 5.018 subjects from the rural community
of Ansung (2.240 men and 2.778 women). Data collected
from the cohort included questionnaires, anthropometric
measurements, blood tests, and clinical examinations by
trained interviewers and examiners. Subjects were followed
biennially during scheduled site visits for a period of 16 years.
For the present study, 1.731 subjects were excluded at baseline
[fasting glucose (n=299), BMI (n=5), TG (n=2), HDL (n=2), CVD
(n=225), BMI<18 (n=161), and diabetes (n=1.203)]. During the
16 year study period, 2.537 out of 8.296 subjects were lost to
follow-up due to death (n=872) and follow-up loss (n=1.665).
Finally, 5.759 subjects remained eligible for this investigation.
This study was approved by the Institutional Review Board
of the Korea University Ansan Hospital, and written informed
consent was given by all study subjects.
Measurements
Study subjects completed questionnaires administered by a
trained interviewer, which included questions on demographic
information, current and past medical conditions, FHD, snoring,
and lifestyle. Subjects were asked “Have you ever heard that you
snored?”, and if so, they asked additional questions about how
frequently they snored (sometimes, 1 to 3 time/week; often,
4 to 5 time/week; frequent, 6 to 7 time/week). Snoring status
of participants were divided into three different groups: nonsnorer (never), occasional snorer (less than 4 nights a week),
and habitual snorer (at least 4 nights a week). The frequency
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of snoring was assessed by an interviewer-administered
questionnaire. Assessments of reliability for the snoring
questionnaire were performed by test retest. The kappa value
for agreement between the two tests was 0.73 (11). BMI was
calculated as weight divided by height squared (kg/m2). World
Health Organization (WHO) expert consultation report that BMI
cut-off points by race show of difference (19). Additional trigger
points for public health action were identified 27.5 kg/m2 or
higher as representing high risk for Asian population. Obesity
was defined as a BMI of 27.5 kg/m2 or more. Positive FHD was
defined based on positive parental history of diabetes. Leisuretime physical activity was calculated using questionnaires
including questions about type of activity, frequency (times
per week), and duration (in minutes). Metabolic equivalents
(MET) values were assigned to each sports activity based on the
compendium of physical activities. Alcohol consumption was
evaluated using questionnaires including kind of drink (beer,
wine, hard liquor, and 3 types of traditional drinks, including
soju, chungju, and makgeolli), amount, and frequency (times
per year). Smoking status was categorized as never, past,
and current. Triglyceride, HDL, and fasting glucose levels
were measured using an ADVIA 1650 Auto Analyzer (Siemens
Medical Solutions, Tarrytown, NY, USA).
Definitions of Diabetes, Hypertension, and Snoring
We used the diagnostic criteria for diabetes and hypertension
proposed by the WHO (20,21). Diabetes was defined as
having a fasting plasma glucose concentration ≥126 mg/dL, or
postprandial 2-h glucose concentration ≥200 mg/dL, or current
treatment by oral anti-diabetic drugs or insulin. Hypertension
was defined as having SBP at least 140 mmHg or DBP at
least 90 mmHg or were being treated with antihypertensive
medication.
Statistical Analysis
Baseline characteristics were expressed as means and standard
deviations for continuous variables and as percentages for
categorical variables. Differences in examinations were
determined using generalized linear models and chi-square
tests. Multiple comparisons were addressed with Scheffe’s
post-hoc tests. To estimate the risk of developing diabetes we
applied Cox proportional hazards regression models (HRs),
95% confidence intervals (CIs), and p-values. The potential
confounding variables adjusted for in multivariate models are
as follows: FHD (yes, no), obese (BMI<27.5, 27.5≤BMI), snoring
status (never, occasional, and habitual), age, smoker (never
smoking, past smoking, and current smoking), exercise (METs),
alcohol consumption (g/day), triglyceride, HDL, fasting glucose,
and hypertension (yes, no). Interaction p-values for these risk
factors were calculated for every possible combination. The
interaction effects for the combination of three risk factors were
analyzed using likelihood ratio tests. Risk factors were combined
as categories to conduct joint analysis, with the reference being
the non-exposure group. A two-tailed p<0.05 was considered
statistically significant. All statistical analyses were performed
using SAS statistical software (SAS 9.4, SAS Institute, Cary, NC,
USA).
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Results
Of the 5.759 individual study subjects, 1.667 (831 of 3.083
women, 836 of 2.676 men) newly developed diabetes during
the 16-year follow-up. Table 1 shows the baseline characteristics
of the subjects stratified by sex. Males had higher mean values
and frequency compared to females as follows: fasting glucose
(85.3±9.3 of men vs. 81.7±8.2 of women), BMI (24.4±2.8 of
men vs. 24.9±3.1 of women), triglyceride (174.2±110.6 of
men vs. 143.8±80.4 of women), exercise (84.3±163.9 of men
vs. 75.9±160.8 of women), alcohol consumption (17.0±26.2 of
men vs. 1.3±5.6 of women), hypertension (29.5% of men vs.
26.2% of women), habitual snorer (17.5% of men vs. 10.8% of
women), past smokers and current (32.5% of men vs. 1.1% of
women and 47.4% of men vs. 3.1% of women, respectively). In
contrast, obese status (13.0% of men vs. 19.5% of women) and
FHD (7.6% of men vs. 8.6% of women) were more frequent
in females. Age and HDL were higher in females (50.7±8.1 of
men vs. 51.5±8.5 of women and 43.3±9.6 of men vs. 45.6±9.8
of women).
Table 2 compares the baseline characteristics among three
groups defined by different frequencies of snoring by sex.
Fasting blood glucose and triglycerides significantly increased
with increasing frequency of snoring in both sexes, and snoring
was associated with higher alcohol consumption, obesity,
and hypertension than in non-snorers. HDL decreased with
increased snoring frequency. Exercise (METs) was increased
in men with increasing snoring frequency. Smoking was not
associated with snoring status in either females or males.
Table 3 shows the crude HRs and multivariable-adjusted HRs
for incident diabetes and snoring status, obesity, and FHD by
gender. In the crude model, snoring, obesity, and FHD were
significantly associated with incident diabetes in both females
and males. After adjustments for covariates, FHD [HR=1.84
(95% CI: 1.47-2.29); p<0.01) for females with positive FHD
and 1.29 (1.02-1.65; p=0.04) for males with positive FHD] and
obesity [HR=1.34 (1.14-1.57; p<0.01) for obese females and
1.24 (1.03-1.50; p=0.02) for obese males] were significantly
associated with increased risk of 16-year incidence of diabetes
in both sexes. However, among females only habitual snorers
showed a significant association with incident diabetes [HR=1.25
(1.01-1.56); p=0.04); this was not seen in males.
Table 4 presents the combined effects of snoring status, obesity,
and FHD on incident diabetes. We divided groups according to
the presence or absence of factors into either four or six groups.
The combined non-exposed groups were used as a reference.
For patients with the combination of FHD and obesity,
multivariate HR for incident diabetes was 1.39 (1.18-1.64;
p<0.01) for negative FHD and being obese, 1.89 (1.47-2.44;
p<0.01) for positive FHD and not being obese, and 2.38 (1.573.60; p<0.01) for positive FHD and being obese, compared
to females who were negative for FHD and were not obese.
The relationship between positive FHD and obesity showed
a different trend in men [HT=1.27 (1.05-1.54; p=0.01 for
negative FHD and obese, 1.36 (1.05-1.76; p<0.01) for positive
FHD and non-obese, 1.24 (0.06-2.40; p=0.53) for positive
FHD and obese]. For the combination of FHD and snorer
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Table 1. Baseline characteristics according to sex
Female

Male

n=3.083

n=2.676

p

Age (years)

51.5±8.5

50.7±8.1

p<0.05

Fasting glucose (mg/dL)

81.7±8.2

85.3±9.3

p<0.05

Body Mass index (kg/m )

24.9±3.1

24.4±2.8

p<0.05

Triglyceride (mg/dL)

143.8±80.4

174.2±110.6

p<0.05

HDL (mg/dL)

45.6±9.8

43.3±9.6

p<0.05

Exercise (MET)

75.9±160.8

84.3±163.9

p<0.05

Alcohol consumption (g/day)

1.3±5.6

17.0±26.2

p<0.05

Obese (27.5≤BMI)

600 (19.5%)

348 (13.0%)

p<0.05

Positive FHD

264 (8.6%)

203 (7.6%)

p<0.05

Hypertension

808 (26.2%)

790 (29.5%)

p<0.05

Snorer

-

-

p<0.05

Non-snorers

1.386 (45.0%)

930 (34.8%)

-

Occasional snorers

1.364 (44.2%)

1.279 (47.8%)

-

Habitual snorers

333 (10.8%)

467 (17.5%)

-

Smoker

-

-

p<0.05

Never smoking

2.955 (95.9%)

539 (20.1%)

-

Past smoking

33 (1.1%)

869 (32.5%)

-

Current smoking

95 (3.1%)

1.268 (47.4%)

-

2

BMI: Body Mass index, FHD: Family history of diabetes

status, multivariate HRs for incident diabetes were associated
with FHD and snoring status in females [HR=1.28 (1.02-1.61);
p=0.03 for negative FHD and habitual snorers, 1.60 (1.112.31; p=0.01) for positive FHD and non-snorers, 2.09 (1.532.86; p<0.01) for positive FHD and occasional snorers, 3.14
(1.87-5.30; p<0.01) for positive FHD and habitual snorers].
In males, incident diabetes was associated with positive FHD
only in occasional snorers [1.43 (1.03-1.99; p=0.03)]. For the
combination of obesity and snoring status, multivariate HRs
for incident diabetes were HR=1.21 (1.02-1.44; p=0.03) for
non-obese and occasional snorers, 1.45 (1.10-1.90; p=0.01)
for non-obese and habitual snorers, 1.71 (1.31-2.23; p<0.01)
for obese and non-snorers, 1.48 (1.18-1.86; p<0.01) for obese
and occasional snorers, and 1.61 (1.19-2.17; p<0.01) for obese
and habitual snorers in women. In males, multivariate HR for
incident diabetes was 1.35 (1.04-1.76; p=0.027) for obese and
occasional snorers. The linear trend p-values were significant in
females, but not in males except for the multivariate model of
snoring and obesity. After adjustments for prominent diabetes
risk factors, the interaction p-value was only significant in
females.
Table 5 shows the effects of 12 combinations of three risk
factors including snoring status, FHD, and obesity. After
adjustments for other confounding factors, divided groups
showed significant associations with non-exposed groups
among females, except for obese non-snorers with positive
FHD. In particular, an exposure group with all three factors
had higher diabetes risk than other groups [HR=6.27 (2.9313.41) p<0.01]. For detail analysis of women, we divided
premenopausal and postmenopausal. Premenopausal women

was showed significant in positive group of positive of FHD,
obese, habitual snorer [HR=5.69 (95% CI: 2.31-14.02) p<0.01].
But, postmenopausal women was showed significant in positive
FHD and habitual snorer both non-obese and obese [HR=7.22
(95% CI: 1.68-30.99) p=0.01 and HR=7.85 (95% CI: 1.8832.82) p<0.01, respectively]. In men, obesity with occasional
snoring in negative FHD, and lack of obesity with occasional
snoring in positive FHD were significantly associated with
increased risk for diabetes. The linear trend p-value and
interaction p-value was significant in females (p<0.01 and
p<0.01, respectively) but not in males.

Discussion
In this prospective cohort study, we explored the synergistic
effects between three known risk factors for the onset of
diabetes, including snoring status, FHD, and obesity, using a
joint model. Findings from the majority of earlier studies have
consistently shown significant associations between obesity,
FHD, and the combination of both with diabetes. We observed
strong associations between incident diabetes, FHD, and
obesity in both females and males. Previous studies agreed with
the results of the present study by showing that female habitual
snorers were more likely to have incident diabetes. The diabetes
risk associated with habitual snoring is controversial in males.
Our results revealed sex differences in the relationship between
habitual snoring and incident diabetes. In a synergistic effect,
coexistent habitual snoring may elevate incident diabetes risk
in females although obesity and FHD are both main risk factors
for developing diabetes. However, the same relationship for
male habitual snorers was significant in a crude model, but
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Table 2. Baseline characteristics by sex and snoring status
Snorers

p

Non

Occasional

Habitual

Female

n=1.386

n=1.364

n=333

-

Age (years)

50.5±8.5

51.6±8.4†

54.8±8.4‡*

<0.01

Fasting glucose (mg/dL)

81.1±8.0

82.0±8.3†

82.7±8.6‡

<0.01

Body Mass index (kg/m )

24.3±2.9

25.2±3.1†

26.5±3.2‡*

<0.01

Triglyceride (mg/dL)

136.9±76.0

148.1±84.5†

155.3±78.9‡

<0.01

HDL (mg/dL)

46.2±9.9

45.1±9.7†

45.0±9.9

<0.01

Exercise (MET)

72.4±157.8

81.1±167.3

69.1±144.7

0.26

Alcohol consumption (g/day)

1.0±3.8

1.4±6.9†

1.8±5.6‡

0.03

Obese (27.5≤BMI)

189 (13.6%)

288 (21.1%)†

123 (36.9%)‡*

<0.01

Positive FHD

115 (8.3%)

122 (8.9%)

27 (8.1%)

0.79

Hypertension

276 (19.9%)

404 (29.6%)†

128 (38.4%)‡*

<0.01

Smoker

-

-

-

0.49

Past smoking

15 (1.1%)

13 (1%)

5 (1.5%)

-

Current smoking

39 (2.8%)

41 (3%)

15 (4.5%)

-

Male

n=930

n=1.279

n=467

-

Age (years)

51.7±8.5

50.2±8.0†

50.3±7.5‡

<0.01

Fasting glucose (mg/dL)

84.0±9.0

86.0±9.4†

86.2±9.5‡

<0.01

Body Mass index (kg/m2)

23.6±2.6

24.5±2.7†

25.5±2.8‡*

<0.01

Triglyceride (mg/dL)

166.5±104.0

177.0±116.6†

181.9±105.8

0.02

HDL (mg/dL)

44.4±10.0

43.0±9.4†

41.7±8.6‡*

<0.01

Exercise (MET)

77.9±154.4

86.8±166.2

89.9±175.6

0.32

Alcohol consumption (g/day)

15.6±25.9

17.3±26.1

19.0±26.7

<0.07

Obese (27.5≤BMI)

66 (7.1%)

170 (13.3%)†

112 (24.0%)‡*

<0.01

Positive FHD

53 (5.7%)

106 (8.3%)†

44 (9.4%)‡

0.02

Hypertension

243 (26.1%)

388 (30.3%)†

159 (34.1%)‡

<0.01

Smoker

-

-

-

0.70

Past smoking

288 (31.0%)

429 (33.5%)

152 (32.6%)

-

Current smoking

457 (49.1%)

590 (46.1%)

221 (47.3%)

-

2

†Significant difference between non-snorers and occasional snorers (p<0.05), ‡Significant difference between non-snorers and habitual snorers (p<0.05), *Significant
difference between occasional snorers and habitual snorers (p<0.05), BMI: Body Mass index, MET: Metabolic equivalents, FHD: Family history of diabetes

the significance disappeared after adjustments for confounding
effects. However, the coexistence of obesity with FHD in nonsnorers and occasional snorers was found to be significant. The
interaction terms were not significant in female patients with
FHD obesity, and snoring, possibly due to a lack of statistical
power rather than actual lack of effect. Moreover, Synergistic
effects in premenopausal and postmenopausal women was
showed difference results. Postmenopausal women was showed
significant in positive group FHD and habitual snorer both nonobese and obese.
Diabetes is a chronic metabolic disease with multifactorial
pathogenesis, which is characterized mainly by insulin resistance
and beta cell dysfunction (4). Insulin resistance is a pathologic
condition in which insulin fails to elicit responses in the liver,
skeletal muscle, and adipose tissue, which are peripheral insulin
target tissues. Beta cell dysfunction occurs when beta cells in the
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pancreas fail to produce normal amounts of insulin. Of course,
this process is affected by many factors such as hyperglycemia,
lipotoxicity, inflammation, adipokines, oxidative stress, insulin
resistance, autoimmunity, islet amyloid, and incretins. Beta cell
dysfunction impairs glucose homeostasis, leading to diabetes
(22).
FHD, obesity, and snoring is important risk factors for diabetes.
Familial aggregation studies are important for the identification of
genetic determinants of disease. The contribution of underlying
maternal and paternal influences to diabetes is well studied
(5,23). Offspring of parents with diabetes have higher fasting
glucose, abnormal glucose tolerance (NGT), and prevalence
of diabetes. In addition, family history was strongly associated
with risk of diabetes after adjustments for prominent diabetes
risk factors such as physical activity, BMI, waist circumference,
and multi-SNP genetic risk score (5). Recently, a susceptibility
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Tables 3. Hazard ratios for cumulative 16-year incident diabetes incidence for three risk factors
Crude

Multivariate adjusted

[HR (95%CI) p-value]

[HR (95% CI) p-value]

Negative FHD

Reference

Reference

Positive FHD

1.43 (1.15-1.77) <0.01

1.84 (1.47-2.29) <0.01

Non-obese

Reference

Reference

Obese

1.95 (1.68-2.27) <0.01

1.34 (1.14-1.57) <0.01

Non-snorers

Reference

Reference

Occasional snorers

1.33 (1.15-1.55) <0.01

1.11 (0.96-1.29) 0.16

Habitual snorers

1.80 (1.46-2.22) <0.01

1.25 (1.01-1.56) 0.04

Negative FHD

Reference

Reference

Positive FHD

1.31 (1.04-1.66) 0.02

1.29 (1.02-1.65) 0.04

Non-obese

Reference

Reference

Obese

1.61 (1.35-1.93) <0.01

1.24 (1.03-1.49) 0.02

Non-snorers

Reference

Reference

Occasional snorers

1.17 (1.00-1.37) 0.05

1.03 (0.88-1.20) 0.76

Habitual snorers

1.28 (1.05-1.55) 0.01

1.01 (0.83-1.24) 0.92

Female
FHD
Obesity

Snorers
Male
FHD
Obesity

Snorers

The potential confounding variables adjusted in the multivariate models are as follows: FHD (yes, no), obese (BMI<27.5 kg/m2, 27.5≤BMI), snoring status (never,
occasional, and habitual), age, smoker (never smoking, past smoking, and current smoking), exercise (METs), alcohol consumption (g/day), triglyceride, HDL, fasting
glucose, and hypertension (yes, no).
BMI: Body Mass index, FHD: Family history of diabetes, MET: Metabolic equivalents, CI: Confidence interval

Tables 4. Synergistic effects between two risk factors for incident diabetes
Female

Male

Crude
[HR (95% CI) p-value)

Multivariate
[HR (95% CI) p-value]

Crude
[HR (95% CI) p-value]

Multivariate
[HR (95% CI) p-value]

Non-obese

Reference

Reference

Reference

Reference

Obese

1.99 (1.70-2.34) <0.01

1.39 (1.18-1.64) <0.01

1.70 (1.42-2.04) <0.01

1.27 (1.05-1.54) 0.01

Non-obese

1.51 (1.18-1.94) <0.01

1.89 (1.47-2.44) <0.01

1.45 (1.12-1.86) <0.01

1.36 (1.05-1.76) 0.02

Obese

2.48 (1.65-3.73) <0.01

2.38 (1.57-3.60) <0.01

1.26 (0.65-2.43) 0.49

1.24 (0.64-2.40) 0.53

<0.01

<0.01

<0.01

0.02

Reference

Reference

Reference

Reference

1.32 (1.13-1.54) <0.01

1.12 (0.96-1.31) 0.16

1.15 (0.98-1.35) 0.09

1.04 (0.88-1.23) 0.63

1.75 (1.40-2.18) <0.01

1.28 (1.02-1.61) 0.03

1.33 (1.08-1.62) <0.01

1.11 (0.90-1.36) 0.33

1.31 (0.91-1.88) 0.15

1.60 (1.11-2.31) 0.01

1.39 (0.87-2.22) 0.16

1.58 (0.99-2.54) 0.06

Occasional snorers

1.89 (1.39-2.58) <0.01

2.09 (1.53-2.86) <0.01

1.69 (1.23-2.32) <0.01

1.43 (1.03-1.99) 0.03

Habitual snorers

3.08 (1.83-5.18) <0.01

3.14 (1.87-5.30) <0.01

1.06 (0.60-1.90) 0.84

0.89 (0.50-1.60) 0.71

P-value for trend

<0.01

<0.01

<0.01

0.061

Reference

Reference

Reference

Reference

Occasional snorers

1.34 (1.13-1.59) <0.01

1.21 (1.02-1.44) 0.03

1.10 (0.93-1.30) 0.28

1.00 (0.85-1.19) 0.99

Habitual snorers

1.73 (1.32-2.26) <0.01

1.45 (1.10-1.90) <0.01

1.21 (0.97-1.51) 0.10

1.03 (0.82-1.29) 0.81

2.21 (1.70-2.88) <0.01

1.71 (1.31-2.23) <0.01

1.39 (0.91-2.11) 0.13

1.07 (0.70-1.63) 0.77

Occasional snorers

2.29 (1.84-2.86) <0.01

1.48 (1.18-1.86) <0.01

1.95 (1.52-2.52) <0.01

1.35 (1.04-1.76) 0.03

Habitual snorers

2.71 (2.02-3.63) <0.01

1.61 (1.19-2.17) <0.01

1.64 (1.21-2.24) <0.01

1.18 (0.86-1.63) 0.30

P-value for trend

<0.01

<0.01

<0.01

0.04

Negative FHD
Positive FHD
P-value for trend
Non-snorers

Negative FHD

Occasional snorers
Habitual snorers
Non-snorers

Non-snorers

Non-snorers

Positive FHD

Non-obese

Obese

The potential confounding variables adjusted in the multivariate models are as follows: FHD (yes, no), obese (BMI<27.5, 27.5≤BMI), snoring status (never, occasional,
and habitual), age, smoker (never smoking, past smoking, and current smoking), exercise (METs), alcohol consumption (g/day), triglyceride, HDL, fasting glucose, and
hypertension (yes, no)
BMI: Body Mass index, MET: Metabolic equivalents, FHD: Family history of diabetes, CI: Confidence interval, HR: Hazard ratio
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Tables 5. Synergistic effects between three risk factors for incident diabetes
Multivariate [HR (95% CI) p-value]
Female

Negative FHD

Positive FHD

Reference

1.89 (1.27-2.81) <0.01

Occasional snorers

1.20 (1.00-1.44) 0.05

2.28 (1.58-3.29) <0.01

Habitual snorers

1.43 (1.07-1.91) 0.02

2.59 (1.27-5.25) <0.01

1.84 (1.39-2.42) <0.01

1.34 (0.50-3.62) 0.56

Occasional snorers

1.47 (1.15-1.87) <0.01

2.67 (1.52-4.71) <0.01

Habitual snorers

1.50 (1.09-2.07) 0.01

6.27 (2.93-13.41) <0.01

P-value for interaction

p<0.01

Non-snorers

Non-snorers

Non-obese

Obese

Premenopause

Negative FHD

Positive FHD

Reference

2.03 (1.32-3.14) <0.01

Occasional snorers

1.23 (1.00-1.52) 0.05

2.36 (1.56-3.57) <0.01

Habitual snorers

1.30 (0.92-1.84) 0.13

2.17 (0.96-4.92) 0.06

1.99 (1.46-2.72) <0.01

1.94 (0.72-5.25) 0.19

Occasional snorers

1.42 (1.07-1.89) 0.02

2.48 (1.34-4.59) <0.01

Habitual snorers

1.62 (1.11-2.37) 0.01

5.69 (2.31-14.02) <0.01

P-value for interaction

p<0.01

Non-snorers

Non-snorers

Non-obese

Obese

Postmenopause

Negative FHD

Positive FHD

Reference

1.47 (0.53-4.11) 0.46

Occasional snorers

1.11 (0.76-1.63) 0.59

1.85 (0.81-4.25) 0.15

Habitual snorers

1.72 (1.00-2.97) 0.05

7.22 (1.68-30.99) 0.01

Non-snorers

Non-snorers

Non-obese

1.36 (0.72-2.53) 0.34

-

Occasional snorers

1.63 (1.02-2.62) 0.04

4.99 (1.15-21.58) 0.03

Habitual snorers

1.27 (0.70-2.31) 0.44

7.85 (1.88-32.82) <0.01

P-value for interaction

p<0.01

Male

Negative FHD

Positive FHD

Non-snorers

Obese

Reference

1.68 (1.03-2.72) 0.04

Occasional snorers

1.00 (0.84-1.19) 0.98

1.45 (1.03-2.05) 0.04

Habitual snorers

1.08 (0.86-1.37) 0.50

0.87 (0.45-1.70) 0.69

Non-snorers

Non-obese

1.12 (0.72-1.72) 0.62

0.87 (0.12-6.24) 0.89

Occasional snorers

Obese

1.39 (1.06-1.83) 0.02

1.60 (0.65-3.91) 0.31

Habitual snorers

1.24 (0.89-1.72) 0.20

1.04 (0.33-3.27) 0.95

P-value for interaction

p=0.614

The potential confounding variables adjusted in the multivariate models are as follows: FHD (yes, no), obese (BMI<27.5 kg/m2, 27.5≤BMI), snoring status (never,
occasional, and habitual), age, smoker (never smoking, past smoking, and current smoking), exercise (METs), alcohol consumption (g/day), triglyceride, HDL, fasting
glucose, and hypertension (yes, no).
BMI: Body Mass index, MET: Metabolic equivalents, FHD: Family history of diabetes, CI: Confidence interval, HR: Hazard ratio

locus identified during a GWAS meta-analysis for diabetes was
found to overlap with loci involved in adipocytokine signaling,
cell cycle regulation, and CREBBP-related transcription, all of
which are involved in the pathogenesis of diabetes including
insulin resistance and beta cell function (24). Consequently,
FHD is a better predictor than any other risk factor for diabetes
because it reflects both environmental and genetic factors.
Obesity is an important accelerating risk factor in the
pathogenesis of diabetes through secretion of non-esterified
fatty acids (NEFAs), adipokines (leptin and adiponectin), and
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inflammatory cytokines (TNF alpha, IL-6, and IL-1 beta) to
form adipose tissue, which is chronically increased in obesity
(25). Increased NEFA concentrations are common in obesity
and diabetes and cause insulin resistance by inhibition of
glucose transport and/or phosphorylation with a subsequent
reduction of glucose oxidation and glycogenesis in muscle.
Consequentially, high NEFA concentrations are not only thought
to have a causal relationship with insulin resistance and glucose
intolerance, but also to be a risk factor for transition from IGT to
diabetes (26,27). Adipokines such as leptin and adiponectin are
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predominantly made by adipocytes. Derived TNF alpha, IL-6,
and IL-1 beta from adipose tissue, which induces macrophage
activation and infiltration that enhance the production of these
cytokines (28). These results indicate that cytokines activate the
JNK and NF-kB signals, which results in low grade inflammation
and promotes the generation of ROS and nitrogen. Therefore,
increases in cytokine concentration could be responsible for
increased oxidative stress. In addition, high circulating NEFA
levels influence overproduction of ROS via beta-oxidative
phosphorylation in mitochondria. ROS exert negative regulation
on insulin signaling, inducing the development of insulin
resistance, which is a risk factor for diabetes (22).
In previous studies, habitual snoring was independently
associated with many diseases including abnormalities of insulin
secretion and insulin action, and the prevalence and incidence
of diabetes (8,9,14-17,29). Snoring is produced by vibrations of
the upper airway walls due to partial disturbance of the upper
airway, which is an important signature of sleep-disordered
breathing (SDB). Impairment to the exchange of gases in
the respiratory system by SDB increases oxygen desaturation.
Eventually, this causes hypoxia and hypercapnia (30). Increased
hypoxia and hypercapnia lead to sympathetic nervous activity,
in which catecholamine, epinephrine and norepinephrine, and
cortisol are released by triggering the physiologic stress response
(31,32). SDB is associated with increased inflammatory markers
such as TNF-alpha, IL-6, hsCRP, which could be secondary to the
combined interactions of obesity and hyperglycemia (33). As a
result, the systemic effect of sympathetic neural hyperactivity,
increased catecholamine and inflammatory markers impair
glucose homeostasis by promoting glucose production through
the activation of glycogenolysis and gluconeogenesis, and
inhibit insulin secretion and insulin mediated glucose uptake
by skeletal muscles (34,35). This in turn causes an increase of
circulating insulin and increased risk of insulin resistance, which
may result in diabetes (36).
The menopause condition is associated with several physiological
change that may impact women heath outcome. Hormonal
change in postmenopausal women lead to increased fat mass
and abdominal fat, and decreased lean body mass comparison
of premenopausal women, which have been linked to insulin
sensitivity and glucose metabolism (37).
Because diabetes is a multifactorial disease resulting from
complex interplays of many risk factors, it is very important to
understand the interaction between risk factors. In previous
studies, the coexistence of obesity and FHD in females showed
an increased combined effect on NGT, IGT, and diabetes
(8,9,29). Consequently, the effect of combined obesity, FHD,
and snoring on the development of diabetes seems to be due
to amplification of inflammatory cytokine signals and ROS
production.
The general public recognizes the connections between obesity,
FHD, habitual snoring, and diabetes, but remains unaware
of synergistic effects that occur due to their combination.
Our results suggest that the coexistence of obesity, FHD, and
habitual snoring increases susceptibility to diabetes in females.
But coexistence of these risk factors was not found in males.

Study Limitations
Limitation of this study was small sample size because groups
were stratified. Future research will require larger sample sizes.
In addition, the effects of the coexistence of obesity, FHD, and
snoring on cardiovascular diseases, morbidity, and mortality
should also be studied.

Conclusion
Obesity, FHD, and snoring are easily accessible without special
screening, the results of this study will increase the understanding
of diabetes and potentially contribute to the prevention of
diabetes by promoting voluntary lifestyle changes.
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